GW&K Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102K Sell
1,179
-58
-5% -$5.56K ﹤0.01% 451
2025
Q4
$119K Buy
1,237
+41
+3% +$3.98K ﹤0.01% 436
2025
Q3
$114K Buy
1,196
+8
+0.7% +$735 ﹤0.01% 426
2025
Q2
$104K Buy
1,188
+143
+14% +$12.1K ﹤0.01% 426
2025
Q1
$94K Buy
1,045
+81
+8% +$7.25K ﹤0.01% 412
2024
Q4
$77K Buy
964
+19
+2% +$1.65K ﹤0.01% 422
2024
Q3
$85K Buy
945
+135
+17% +$11.4K ﹤0.01% 408
2024
Q2
$64K Buy
810
+129
+19% +$10.6K ﹤0.01% 420
2024
Q1
$59K Buy
681
+168
+33% +$14.3K ﹤0.01% 410
2023
Q4
$42K Buy
513
+42
+9% +$3.2K ﹤0.01% 422
2023
Q3
$37K Buy
471
+62
+15% +$5.19K ﹤0.01% 418
2023
Q2
$36K Buy
+409
New +$35.2K ﹤0.01% 405
2022
Q3
Sell
-99
Closed -$9K 661
2022
Q2
$9K Sell
99
-7
-7% -$709 ﹤0.01% 483
2022
Q1
$12K Buy
+106
New +$11.2K ﹤0.01% 423

Other funds holding MDT

GW&K Investment Management's MDT Position: Q1 2026 in Review

GW&K Investment Management reduced its Medtronic (MDT) stake by 4.7% in Q1 2026, selling an estimated $5.56K and leaving 1,179 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

GW&K Investment Management first reported a position in MDT in Q1 2022 and has held it in 14 quarters since. The position peaked at $119K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • GW&K Investment Management held 1,179 shares of Medtronic worth $102K as of Q1 2026.
  • GW&K Investment Management sold 58 Medtronic shares in Q1 2026, an estimated $5.56K.
  • Medtronic made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #451 holding.
  • GW&K Investment Management first reported a position in Medtronic in Q1 2022 and has held it in 14 quarters since.
  • GW&K Investment Management's Medtronic position peaked at $119K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.